Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation

Abstract

Canine copper toxicosis is an autosomal recessive disorder characterized by hepatic copper accumulation resulting in liver fibrosis and eventually cirrhosis. We have identified COMMD1 as the gene underlying copper toxicosis in Bedlington terriers. Although recent studies suggest that COMMD1 regulates hepatic copper export via an interaction with the Wilson disease protein ATP7B, its importance in hepatic copper homeostasis is ill-defined. In this study, we aimed to assess the effect of Commd1 deficiency on hepatic copper metabolism in mice. Liver-specific Commd1 knockout mice (Commd1Δhep) were generated and fed either a standard or a copper-enriched diet. Copper homeostasis and liver function were determined in Commd1Δhep mice by biochemical and histological analyses, and compared to wild-type littermates. Commd1Δhep mice were viable and did not develop an overt phenotype. At six weeks, the liver copper contents was increased up to a 3-fold upon Commd1 deficiency, but declined with age to concentrations similar to those seen in controls. Interestingly, Commd1Δhep mice fed a copper-enriched diet progressively accumulated copper in the liver up to a 20-fold increase compared to controls. These copper levels did not result in significant induction of the copper-responsive genes metallothionein I and II, neither was there evidence of biochemical liver injury nor overt liver pathology. The biosynthesis of ceruloplasmin was clearly augmented with age in Commd1Δhep mice. Although COMMD1 expression is associated with changes in ATP7B protein stability, no clear correlation between Atp7b levels and copper accumulation in Commd1Δhep mice could be detected. Despite the absence of hepatocellular toxicity in Commd1Δhep mice, the changes in liver copper displayed several parallels with copper toxicosis in Bedlington terriers. Thus, these results provide the first genetic evidence for COMMD1 to play an essential role in hepatic copper homeostasis and present a valuable mouse model for further understanding of the molecular mechanisms underlying hepatic copper homeostasis.

About the Authors:

Willianne I. M. Vonk

Affiliations Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, and Netherlands Metabolomics Center, Utrecht, The Netherlands, Complex Genetics Section, University Medical Center Utrecht, Utrecht, The Netherlands

Paulina Bartuzi

Affiliation: Department of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Prim de Bie

Current address: Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel

Affiliations Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, and Netherlands Metabolomics Center, Utrecht, The Netherlands, Complex Genetics Section, University Medical Center Utrecht, Utrecht, The Netherlands

Niels Kloosterhuis

Affiliation: Department of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Catharina G. K. Wichers

Affiliation: Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, and Netherlands Metabolomics Center, Utrecht, The Netherlands

Ruud Berger

Affiliation: Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, and Netherlands Metabolomics Center, Utrecht, The Netherlands

Susan Haywood

Affiliation: Department of Veterinary Pathology, Faculty of Veterinary Science, University of Liverpool, Liverpool, United Kingdom

Leo W. J. Klomp

Affiliation: Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, and Netherlands Metabolomics Center, Utrecht, The Netherlands

Cisca Wijmenga

Affiliations Complex Genetics Section, University Medical Center Utrecht, Utrecht, The Netherlands, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Bart van de Sluis

* E-mail: [email protected]

Affiliation: Department of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Introduction

As a redox catalyst, the trace element copper is essential to the well-being of all living organisms (reviewed by [1], [2], [3], [4]), in excess however, copper can be highly toxic due to its participation in the formation of reactive oxygen species (ROS). It is therefore important to maintain a strict balance between the essentiality and the toxicity of copper, and this involves a range of mechanisms mediating copper uptake, transport, storage and excretion. The importance of a balanced copper homeostasis in preventing toxicity is clearly illustrated by various inherited hepatic copper storage disorders such as Wilson disease (WD; OMIM #277900), Indian childhood cirrhosis (ICC; OMIM #215600), endemic Tyrolean infantile cirrhosis (ETIC; OMIM #215600) and idiopathic copper toxicosis (ICT; OMIM #215600). In WD, mutations in the ATP7B gene lead to copper accumulation in different tissues, particularly in liver and brain. The genetic defects underlying ICC, ETIC and ICT remain elusive, but the clinical manifestation of these non-Wilsonian copper storage disorders depends in most cases on an excessive dietary intake of copper [5], [6], [7].

Another well-documented copper overload disorder is copper toxicosis (CT) in Bedlington terriers. CT is an autosomal recessive disease linked to a homozygous genomic deletion, encompassing exon 2, of the COMMD1 gene [8]. Affected dogs are characterized by hepatic copper overload, due to an inefficient copper excretion via the bile, resulting in liver fibrosis and eventually cirrhosis [9], [10]. In contrast to WD, Bedlington terriers affected with CT do not display any signs of neurological defects and have normal serum concentrations of the copper-bound ferroxidase ceruloplasmin (Cp) [10]. Although COMMD1 has been suggested as a candidate gene for the non-Wilsonian copper storage disorders ICC, ETIC and ICT, no mutations in COMMD1 have been identified in these patients so far [11], [12].

The 21 kDa ubiquitously expressed COMMD1 protein is considered as the prototype of the COMMD protein family, which is highly conserved between eukaryotes and in some protozoa [13], [14]. The ten COMMD family members (COMMD1 −10) share a C-terminal COMM domain of 70–85 amino acids that mediates protein-protein interactions and nuclear export of COMMD proteins [15], [16], [17]. Except for COMMD1, the functions of most of the COMMD proteins are largely unknown. Several studies on COMMD1 have provided supportive evidence of its role in copper homeostasis. First, COMMD1 interacts with the copper transporter ATP7B, and is suggested to regulate its proteolysis [18], [19], [20]. Second, down-regulation of COMMD1 expression results in increased intracellular copper concentrations both in HEK293T cells and the mouse hepatoma Hepa1-6 cells [20], [21]. Third, we recently demonstrated that the copper transporting activity of ATP7A, a copper transporter with high homology to ATP7B, is also mediated by COMMD1 expression [22]. Besides its role in copper homeostasis, COMMD1 is also implicated in several other pathways, such as sodium transport, antioxidant defense, and NF-κB and hypoxia signaling [17], [23], [24], [25], [26], [27], [28], [29], [30]. Interestingly, in contrast to dogs deficient for COMMD1, a genetic deletion of Commd1 in mice results in embryonic lethality [31]. Altogether, these data illustrate that COMMD1 is a protein with a pleiotropic function, although its role in hepatic copper metabolism is still not well defined. To gain more insight into the function of COMMD1 in hepatic copper homeostasis in particular, and to circumvent the embryonic lethality of the Commd1 knockout mice, we generated a hepatocyte-specific Commd1 knockout mouse. Here, we provide the first genetic evidence that Commd1 is essential for hepatic copper excretion as Commd1-deficient mice show increased intrahepatic copper levels when their dietary copper intake is increased.

Results

Generation of a hepatocyte-specific Commd1 knockout mouse model

To circumvent embryonic lethality in Commd1-deficient mice and thus study the function of Commd1 in vivo, we generated a conditional Commd1 knockout mouse. A Commd1 targeting construct was designed to flank exon 1 of Commd1 with loxP recombination sites by homologous recombination (Figure 1A). After confirming homologous recombination by long–range PCR (data not shown), the mice were further genotyped by multiplex PCR as described in Materials and Methods and Figure 1B. Germline deletion of Commd1 resulted in embryonic lethality between days 9.5 and 10.5 of gestation (data not shown), similar to what we have demonstrated previously [31].

[Figure omitted. See PDF.]

Figure 1. Generation of hepatocyte-specific Commd1 knockout mouse.

A.) Schematic representation of the Commd1 gene-targeting strategy to generate a hepatic-specific Commd1 knockout mouse, including a map of the COMMD1 exon 1 allele and the targeting vector with loxP sites (solid boxes), FRT sites (open boxes), and neomycin selection gene (Neo). Homologous recombination is marked with dotted lines. Hepatocyte-specific deletion of Commd1 was accomplished by cross-breeding of Commd1loxP/loxP mice with Alb-Cre mice. This resulted in the generation of Commd1Δhep mice (null allele). The locations of the PCR primer (P1, P2 and P3) binding sites used for genotyping are shown as open arrows. (Expected fragments: WT: 500 bp, LoxP: 350 bp, Null: 300 bp) B.) PCR analysis of liver tissue DNA of Commd1 WT, WT/loxP, loxP/loxP and Null/WT mice at six weeks of age. C is a negative control (H2O). C.) Immunoblot analysis of Commd1 expression in liver tissue of Commd1loxP/loxP and Commd1Δhep mice. 30 µg tissue homogenates were analyzed by SDS-PAGE, and immunoblotted (IB) for Commd1 and α-Tubulin expression.

https://doi.org/10.1371/journal.pone.0029183.g001

To elucidate the role of COMMD1 in hepatic copper metabolism, we deleted Commd1 specifically in hepatocytes using the transgenic Albumin-Cre (Alb-Cre) mice (Figure S1), referred to as Commd1Δhep mice from here onwards. Commd1Δhep mice were born in the expected Mendelian frequency. The total body and liver weights of the Commd1Δhep mice were comparable to control littermates (Commd1loxP/loxP) (Table S1). Immunoblot analyses of liver homogenates prepared from Commd1Δhep mice showed an almost complete loss of Commd1 expression relative to Commd1loxP/loxP mice (Figure 1C). As expected, a residual Commd1 expression was observed as the Alb-Cre transgene is selectively expressed in the parenchymal cells, but not in the non-parenchymal cells present in the liver (e.g. Kupffer, endothelial, and stellate cells) [32]. Commd1 expression in other tissues of the Commd1Δhep mice was unaffected (data not shown).

Ablation of hepatic Commd1 results in elevated copper concentrations in the livers of young mice

Since loss of COMMD1 in Bedlington terriers results in hepatic copper accumulation, we investigated the consequence of hepatic Commd1 deficiency on the amount of hepatic copper in the livers of Commd1Δhep mice of different ages (6, 9, 12, 34, 46 and 58 weeks; Table S1). At an age of six weeks, hepatic copper concentrations were significantly increased in Commd1Δhep mice compared to control animals (Commd1loxP/loxP) (46.2±9.9 vs. 13.7±2.0 µg/g dlw, respectively; Figure 2A and Table S1). However, during adolescence, the amount of copper in the livers of Commd1Δhep mice declined to levels similar to those of the control mice (Figure 2A and Table S1). Although hepatic Commd1 ablation resulted in elevated hepatic copper pools, analysis of the mRNA expression of the copper-responsive genes metallothionein I and II (Mt-I and Mt-II) revealed no significant changes between six week-old Commd1Δhep and Commd1loxP/loxP mice (Figure 2B). Interestingly, the protein levels of Atp7b were markedly reduced in the livers of Commd1Δhep mice at this age (Figure 2C, 2D), while the Atp7b mRNA expression remained unaffected (Figure 2E). However, over time, Atp7b increased to levels comparable to those seen in control mice (Figure 2F), and correlated perfectly with the decline in hepatic copper concentrations in Commd1Δhep mice, starting at an age of nine weeks (Figure 2A and Table S1). Further, no alterations in the serum Cp activity or protein levels could be detected in six week-old Commd1Δhep compared to Commd1loxP/loxP mice in spite of the reduced Atp7b levels upon Commd1 deficiency (Table S1 and data not shown). As no differences in serum Cp activity were seen between the two groups at all studied ages (Table S1), our data imply that incorporation of copper into Cp in the trans-Golgi network is not affected by hepatic Commd1 ablation.

[Figure omitted. See PDF.]

Figure 2. Ablation of hepatic Commd1 expression results in increased intracellular copper concentrations accompanied with decreased Atp7b expression in young mice.

A.) Hepatic copper concentrations were measured in dried liver tissue of Commd1loxP/loxP (white bars; n = 6) and Commd1Δhep mice (black bars; n = 5) (6, 9 and 12 weeks of age) by means of FAAS. Data are represented as the hepatic copper concentrations (µg/g dry liver weight) in all mice at indicated ages. * indicates significantly different values compared to Commd1loxP/loxP mice (p<0.05). B.) Relative mRNA expression of metallothioneins Mt-I and Mt-II in liver tissue of Commd1loxP/loxP (open dots; n = 6) and Commd1Δhep mice (black dots; n = 5) (six weeks of age) as determined by qPCR analysis. Expression was normalized for β-Actin mRNA levels, and relatively expressed to Commd1loxP/loxP mice. C.) Immunoblot analysis of liver tissue of Commd1loxP/loxP and Commd1Δhep mice at six weeks of age. 30 µg of liver homogenates were analyzed by SDS-PAGE, and immunoblotted (IB) for expression of Atp7b and Commd1. Actin protein expression was used as the loading control. D.) Densitometric quantification of Atp7b expression at six weeks of age (Figure 2C), normalized to Actin expression. Mean expression of Commd1loxP/loxP mice was set at 1 ± SD. p = 0.0010. E.) Relative mRNA expression of Atp7b in liver tissue of Commd1loxP/loxP (open dots; n = 5–6) and Commd1Δhep mice (black dots; n = 5–6) (6, 9 and 12 weeks of age) as determined by qPCR analysis. Expression was normalized for β-Actin mRNA levels, and relatively expressed to Commd1loxP/loxP mice. F.) Immunoblot analysis of Atp7b expression in liver tissue of Commd1loxP/loxP and Commd1Δhep mice at 12 and 52 weeks of age.

https://doi.org/10.1371/journal.pone.0029183.g002

Despite the increased hepatic copper levels in six week-old Commd1Δhep mice, no overt macroscopic nor microscopic differences were identified between livers of Commd1Δhep and Commd1loxP/loxP mice (data not shown). Furthermore, copper deposits could not be visualized in Commd1Δhep mice livers (data not shown). Consistent with the absence of liver pathology, no differences in the liver enzyme serum levels of glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) were observed (Table S1). Taken together, these data demonstrate that ablation of hepatic Commd1 results in a temporary copper accumulation in young mice without inducing any hepatocellular damage.

Progressive hepatic copper accumulation in Commd1Δhep mice fed a high copper diet

Since the occurrence of copper toxicosis is often dependent on dietary copper intake [5], [6], [7], [9], we challenged Commd1Δhep and control mice with a copper-enriched diet and followed them over time. For this, CuCl2 was supplemented to the drinking water to a final concentration of 6 mM (fed ad libitum). High dietary copper had no effect on the total body and liver weights of either Commd1loxP/loxP or Commd1Δhep mice (Table S2), but clearly affected the hepatic copper concentrations (Figure 3A and Table S2). After three weeks of high dietary copper intake, starting at an age of six weeks, Commd1 deficiency resulted in markedly raised hepatic copper relative to Commd1loxP/loxP mice fed a standard diet (195.8±58.9 vs. 22.6±7.9 µg/g dlw, respectively). In contrast, the hepatic copper concentrations of Commd1loxP/loxP mice were unaffected by the copper-enriched diet (25.8±10.7 vs. 22.6±7.9 µg/g dlw). The highest copper concentrations were measured in the livers of Commd1Δhep mice fed the copper-enriched diet for six weeks (338.3±82.4 vs. 11.8±6.3 µg/g dlw), which subtly declined during aging (Figure 3A and Table S2). This decline in hepatic copper was observed in both genetic groups (Figure 3A and Table S2).

[Figure omitted. See PDF.]

Figure 3. Progressive copper accumulation in livers of Commd1Δhep mice after copper challenging.

A.) Hepatic copper concentrations were measured in dried liver tissue of Commd1loxP/loxP (white bars; n = 4–6) and Commd1Δhep mice (black bars, n = 5–7) (fed a copper-enriched diet for 3, 6, 28, 40 and 52 weeks) by means of FAAS. Data are represented as hepatic copper concentrations (µg/g dry liver weight). *, ** and *** indicate significantly different values compared to Commd1loxP/loxP mice (* p<0.05, ** p<0.005, *** p<0.0005). B.) Relative mRNA expression of metallothioneins Mt-I and Mt-II in liver tissue of Commd1loxP/loxP (open dots; n = 5–6) and Commd1Δhep mice (black dots; n = 5–7) (three and six weeks fed a copper-enriched diet) as determined by qPCR analysis. Expression was normalized for β-Actin mRNA levels, and relatively expressed to Commd1loxP/loxP mice. C.) Immunoblot analysis of Atp7b and Commd1 in liver tissue of Commd1loxP/loxP and Commd1Δhep mice fed a copper-enriched diet for 6 and 52 weeks. D.) Ceruloplasmin activity was determined in sera of Commd1loxP/loxP (white bars; n = 4–6) and Commd1Δhep mice (black bars; n = 5–7) fed a copper-enriched diet for 3, 6, 28, 40 and 52 weeks. Data are represented as serum holoceruloplasmin activity (U/ml). * and ** indicate significantly different values compared to Commd1loxP/loxP mice (* p<0.05, ** p<0.01).

https://doi.org/10.1371/journal.pone.0029183.g003

Although a significant accumulation in hepatic copper was observed in Commd1Δhep mice fed a high copper diet, no macroscopic or microscopic alterations in their liver pathologies were identified (Figure S2 and data not shown). Neither were there differences in the enzymatic activities of serum GOT and GPT between the two groups (Table S2). Additionally, histological hepatic copper deposits were undetectable in Commd1Δhep mice (data not shown). It was noteworthy that mRNA expression of Mt-I and Mt-II was significantly increased in the livers of Commd1Δhep mice fed the copper-enriched diet for three weeks compared to controls. However, no differences in Mt-I and Mt-II expression were seen between the two genetic groups fed the copper-enriched diet for six or more weeks (Figure 3B and data not shown). Furthermore, we did not observe any differences in hepatic Atp7b levels between Commd1loxP/loxP and Commd1Δhep mice (Figure 3C). Yet, during aging, the serum Cp activity of Commd1Δhep mice (28, 40 and 58 weeks old) was significantly increased relative to controls (Figure 3D and Table S2).

Altogether, these results show that liver-specific Commd1-deficient mice are susceptible to progressively accumulate hepatic copper when overexposed to environmental copper. However, hepatic deletion of Commd1 does not affect the incorporation of copper into Cp.

Discussion

Although a genomic deletion of COMMD1 is associated with CT in Bedlington terriers, the significance of COMMD1 in mammalian copper homeostasis remains poorly defined. Here, we examined the role of COMMD1 in hepatic copper homeostasis using a liver-specific Commd1-deficient mouse model, and were able to provide substantial evidence that Commd1 plays a role in controlling copper homeostasis in hepatocytes. We demonstrated that mice deficient for hepatic Commd1 are more susceptible to hepatic copper accumulation compared to wild-type mice when their dietary copper intake is increased. A significant increase in hepatic copper concentrations was also observed in six week-old Commd1Δhep mice fed a standard diet, but these elevated levels declined during adolescence to concentrations similar as seen in wild-type littermates. This increase in hepatic copper in six week-old Commd1Δhep mice probably results from residual copper pools accumulated in the preweaning period [33], [34]. Dietary studies have not been reported in Bedlington terriers with the homozygous COMMD1 deletion, but since most commercial dog food contains copper levels that exceed the minimum recommended daily intake [10], [35], together with the presented data, suggest that reducing the gastrointestinal copper uptake by decreasing the dietary copper content would be beneficial to the liver pathology of affected dogs.

Although our mouse model partially recapitulates the copper accumulation phenotype of Bedlington terriers affected with CT, the exact mode of COMMD1 action in regulating hepatic copper metabolism remains elusive. However, several assumptions can be drawn from our data. Similar to Bedlington terriers, hepatic Commd1 deficiency in mice does not affect the incorporation of copper into Cp by Atp7b. Importantly, probably due to the increased bioavailable hepatic copper, the biosynthesis of holoceruloplasmin was even enhanced in middle-aged Commd1Δhep mice fed a copper-enriched diet compared to controls. Together with the observation that the copper-induced trafficking of ATP7B to the cell periphery is unaffected in COMMD1-deficient cells [18], [20], it is tempting to speculate that, in excess copper, COMMD1 acts downstream of ATP7B and might be involved in the final step of the secretory pathway to efficiently release copper into the bile. This idea is further supported by the fact that COMMD1 partly localizes to vesicles of the endocytic pathway and cellular membranes, and shows only limited co-localization with ATP7B in HepG2 cells [18], [20]. However, COMMD1 is also implicated in regulating the protein levels of ATP7B [18], [20]. Whereas we previously demonstrated that COMMD1 expression augments the protein degradation of ATP7B in vitro [18], others have shown a decline in Atp7b expression after depletion of Commd1 in the mouse hepatoma Hepa1-6 cells [20]. In line with this latter observation, a marked decrease in hepatic Atp7b in six week-old Commd1Δhep mice was observed, and may account for the increased hepatic copper levels observed in these animals. However, no correlation was seen between the degree of copper accumulation and Atp7b levels in Commd1Δhep mice fed a copper-enriched diet, which argues against the role of impaired Atp7b protein stability in progressive copper accumulation in Commd1-deficient hepatocytes. Additionally, no discrepancies in Atp7b stability in primary Commd1-deficient hepatocytes compared to WT control cells were seen (data not shown). Altogether, our data indicate that COMMD1 controls hepatic copper homeostasis downstream of ATP7B and may participate in the release of copper into the bile. Further studies are however needed to complete our understanding on the molecular function of COMMD1 in hepatic copper homeostasis.

Interestingly, although Commd1Δhep mice fed a copper-enriched diet displayed a progressive increase in hepatic copper, no obvious liver pathology using histological analysis were seen, even after chronic exposure to high dietary copper. These data, supported by biochemical parameters and together with the observation that the mRNA expression of the copper-responsive genes Mt-I and Mt-II was only increased in mice fed a copper-enriched diet for three weeks, suggest that the accumulating copper upon Commd1 deletion is stored safely and does not reach a threshold concentration sufficient to induce hepatocellular toxicity as seen in CT-affected Bedlington terriers and mouse models for WD [9], [10], [36]. Potentially, under these studied conditions, the levels of Mt-I and Mt-II are sufficient to chelate the elevated copper. Therefore, it would be of interest to complementary deplete Mt-I and Mt-II [37] in our hepatic-specific Commd1 knockout mice and assess the protective role of Mt-I and Mt-II in copper toxicity in the absence of Commd1. In contrast to Commd1Δhep mice fed a high copper diet, which display copper concentrations of approximately 340 µg/g of dlw, CT-affected dogs with moderate to severe liver pathology show significantly more hepatic copper, often in excess of 1,000 µg/g of dlw. The reason for the interspecies differences is currently unknown and further studies are required. Of particular interest in this would be defining the degree of redundancy between the members of the Commd protein family in murine copper homeostasis, as in addition to COMMD1, COMMD2, 8 and 10 have also the ability to interact with ATP7B (Figure S3A). Importantly, these interactions are independent of COMMD1 expression (Figure S3B).

Together, our data conclusively shows that COMMD1 plays a significant role in copper homeostasis and demonstrates that hepatic copper accumulation due to loss of Commd1 is dependent on excessive dietary copper intake. Given that elevated asymptomatic hepatic copper in Atp7b deficient mice has a significant effect on different metabolic pathways, such as lipid metabolism [38], [39], [40], it would be of interest to investigate whether diet-induced copper accumulation in Commd1Δhep mice also affects these pathways. We believe that our Commd1Δhep mice represent a valuable and interesting model for further elucidating the molecular mechanism controlling hepatic copper homeostasis and to understand the role of excess copper in various metabolic pathways.

Materials and Methods

Generation and housing of transgenic mice

Detailed information regarding the generation of the hepatocyte-specific Commd1 knockout mice is available in Data S1 and Figure S1. Mice were genotyped by a standard PCR method using the primers as described in Table S3, and fed ad libitum with a standard rodent diet containing 16.44 mg copper per kg (Special Diet Services Ltd., UK). Animals of both sexes were included in this study, and age-matched siblings were used as controls in all experiments. All animal protocols (ID 2007.III.09.123) were approved by the Institutional Animal Care and Use Committee of Utrecht University (Utrecht, the Netherlands).

Copper treatment of mice

Starting from the age of six weeks, a subset of mice (consisting of genotypes Commd1loxP/loxP and Commd1Δhep; n = 5–8) were given water supplemented with 6 mM CuCl2. As described previously, these mice ingested approximately 50–100 times more copper than mice fed a standard rodent diet [41].

Tissue preparation, protein isolation and immunoblot analysis

Mice were sacrificed and tissues were rapidly isolated, frozen in liquid nitrogen, and stored at −80°C until use. Dissected tissues were homogenized in ice-cold lysis buffer (25 mM kPi buffer; pH 7.4, 0.5 M EDTA), supplemented with 100 mM PMSF and protease inhibitors (Complete; Roche, Basal, Switzerland)). After centrifugation, supernatants were used for further procedures. Protein concentrations were determined by the Bradford Protein Assay (Bio-Rad Laboratories Inc., Hercules, CA, USA).

Western blot analyses were performed using the following antibodies: rabbit-anti-COMMD1 antiserum [42], polyclonal rabbit-anti-Atp7b antiserum (kindly provided by Dr. J. Gitlin, St. Louis, MO, USA), polyclonal rabbit-anti-Actin (Sigma-Aldrich, St. Louis, MO, USA), and rabbit-anti-α-Tubulin (Abcam, Cambridge, UK). In all analyses, equal amounts of proteins were loaded on SDS-PAGE gels prior to transfer on to nitrocellulose membranes.

RNA isolation and quantitative - RT-PCR

Total RNA was isolated from mouse liver by means of TRIZOL® (Invitrogen Life Technologies Corporation, Carlsbad, CA, USA). cDNA synthesis was performed using random hexamers and SuperScript II reverse transcriptase (Invitrogen). mRNA expression of Mt-I, Mt-II and Atp7b (primers previously described by Huster et al. [36]) was analyzed by quantitative PCR using iTaq™ SYBR®Green Supermix with ROX (Bio-Rad) and 7900 HT Fast Real-Time PCR System (Applied Biosystems, Carlsbad, CA, USA). Results were presented as relative mRNA expression, normalized to the expression of β-Actin (primer sequences available on request).

Determination of hepatic copper concentrations

Liver tissues were dried at approximately 100°C until their weights were stabilized. Dried tissues were digested for 1 h in HNO3∶H2O2 (ratio 3∶1) at 95–100°C. After digestion, volumes were equalized and copper concentrations were determined by means of flame atomic absorption spectrometry (FAAS; Analytik Jena ContrAA® 700, Analytik Jena AG, Jena, Germany). Hepatic copper concentrations were corrected for dry liver weight (dlw) and protein concentration.

Enzyme activity assays

Activity of the glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) were quantified in serum according to the manufacturer's protocol (Spinreact, Sant Esteve De Bas, Spain). Serum Cp activity was measured as described previously [43].

Statistical analysis

The quantitative data in this paper is represented as means ± SEM, unless stated otherwise. Statistical evaluation was made using the Student's t-test and differences were considered to be significant at p<0.05.

Additional Materials and Methods can be found in the Data S1.

Supporting Information

[Figure omitted. See PDF.]

Figure S1.

Generation of hepatocyte-specific Commd1 knockout mouse. Schematic representation of the Commd1 gene-targeting strategy used to generate a hepatic specific Commd1 knockout mouse, including a map of the COMMD1 exon1 allele, the targeting vector with loxP sites (solid boxes), FRT sites (open boxes), and neomycin selection gene (Neo). Different restriction sites are indicated and homologous recombination is marked with dotted lines. The neomycin selection cassette was deleted by crossbreed with the FLPe deleter mice, which target the FRT sequences flanking neomycin. Subsequently, hepatocytespecific deletion of Commd1 was accomplished by crossbreed of Commd1loxP/loxP mice with Alb-Cre mice. This resulted in the generation of Commd1Δhep mice (null allele). The locations of the PCR primer (P1, P2 and P3) binding sites used for genotyping are shown as open arrows.

https://doi.org/10.1371/journal.pone.0029183.s001

(TIF)

Figure S2.

Commd1Δhep mice do not display any pathological abnormalities relative to Commd1loxP/loxP mice. Liver sections (4 µm) of Commd1loxP/loxP and Commd1Δhep mice fed a copper-enriched diet for 6 weeks were stained with H&E, and analyzed by light microscopy (magnification 10×).

https://doi.org/10.1371/journal.pone.0029183.s002

(TIF)

Figure S3.

COMMD2, COMMD8 and COMMD10 interact with ATP7B, independently of COMMD1. A.) Gluthatione-sepharose (GSH) precipitation of HEK293T cell lysates transfected with cDNA constructs encoding GST or each of the COMMD proteins fused to GST in combination with ATP7B-Flag. Precipitates were washed and separated by SDS-PAGE and immunoblotted as indicated. Input indicates direct analyses of cell lysates. B.) HEK293T cells expressing a stable knockdown of COMMD1 (shCOMMD1) were transfected with cDNA constructs encoding an empty vector (pEBB) or ATP7B-Flag in combination with either COMMD2, COMMD8, or COMMD10 as GST fusion proteins as indicated. HEK293T cells stably transfected with an empty shRNA vector was used as a negative control (shControl). GSH precipitation and immunoblot analysis was performed as described under S3A. Equal loading was confirmed by immunoblotting for SCHAD.

https://doi.org/10.1371/journal.pone.0029183.s003

(TIF)

Table S1.

Biological parameters of Commd1loxP/loxP and Commd1Δhep mice fed a standard diet.

https://doi.org/10.1371/journal.pone.0029183.s004

(PDF)

Table S2.

Biological parameters of Commd1loxP/loxP and Commd1Δhep mice fed a high Cu diet, starting at an age of 6 weeks.

https://doi.org/10.1371/journal.pone.0029183.s005

(PDF)

Table S3.

Oligonucleotide sequences used for genotyping mice.

https://doi.org/10.1371/journal.pone.0029183.s006

(DOC)

Data S1.

Supplementary Materials and Methods .

https://doi.org/10.1371/journal.pone.0029183.s007

(DOC)

Acknowledgments

We thank the members of the Pharmaceutical Department (University Medical Center Utrecht, Utrecht, The Netherlands) for the use of the FAAS and their support. We acknowledge Dr. J. Gitlin for kindly providing the rabbit-anti-Atp7b antiserum. We thank Jackie Senior for critically reading the manuscript.

Author Contributions

Conceived and designed the experiments: WIMV CW BvdS. Performed the experiments: WIMV PB PdB NK CW BvdS. Analyzed the data: WIMV PB PdB SH BvdS. Contributed reagents/materials/analysis tools: RB LK CW BvdS. Wrote the paper: WIMV SH CW BvdS.

Citation: Vonk WIM, Bartuzi P, de Bie P, Kloosterhuis N, Wichers CGK, Berger R, et al. (2011) Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation. PLoS ONE6(12): e29183. https://doi.org/10.1371/journal.pone.0029183

References

1. Pena MM, Lee J, Thiele DJ (1999) A delicate balance: homeostatic control of copper uptake and distribution. J Nutr 129: 1251–1260.MM PenaJ. LeeDJ Thiele1999A delicate balance: homeostatic control of copper uptake and distribution.J Nutr12912511260

2. Prohaska JR, Gybina AA (2004) Intracellular copper transport in mammals. J Nutr 134: 1003–1006.JR ProhaskaAA Gybina2004Intracellular copper transport in mammals.J Nutr13410031006

3. Lutsenko S (2010) Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol 14: 211–217.S. Lutsenko2010Human copper homeostasis: a network of interconnected pathways.Curr Opin Chem Biol14211217

4. Wijmenga C, Klomp LW (2004) Molecular regulation of copper excretion in the liver. Proc Nutr Soc 63: 31–39.C. WijmengaLW Klomp2004Molecular regulation of copper excretion in the liver.Proc Nutr Soc633139

5. Pankit AN, Bhave SA (2002) Copper metabolic defects and liver disease: environmental aspects. J Gastroenterol Hepatol 17: Suppl 3S403–407.AN PankitSA Bhave2002Copper metabolic defects and liver disease: environmental aspects.J Gastroenterol Hepatol17Suppl 3S403407

6. Muller T, Feichtinger H, Berger H, Muller W (1996) Endemic Tyrolean infantile cirrhosis: an ecogenetic disorder. Lancet 347: 877–880.T. MullerH. FeichtingerH. BergerW. Muller1996Endemic Tyrolean infantile cirrhosis: an ecogenetic disorder.Lancet347877880

7. Tanner MS (1998) Role of copper in Indian childhood cirrhosis. Am J Clin Nutr 67: 1074S–1081S.MS Tanner1998Role of copper in Indian childhood cirrhosis.Am J Clin Nutr671074S1081S

8. van De Sluis B, Rothuizen J, Pearson PL, van Oost BA, Wijmenga C (2002) Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet 11: 165–173.B. van De SluisJ. RothuizenPL PearsonBA van OostC. Wijmenga2002Identification of a new copper metabolism gene by positional cloning in a purebred dog population.Hum Mol Genet11165173

9. Owen CA Jr, Ludwig J (1982) Inherited copper toxicosis in Bedlington terriers: Wilson's disease (hepatolenticular degeneration). Am J Pathol 106: 432–434.CA Owen JrJ. Ludwig1982Inherited copper toxicosis in Bedlington terriers: Wilson's disease (hepatolenticular degeneration).Am J Pathol106432434

10. Su LC, Ravanshad S, Owen CA Jr, McCall JT, Zollman PE, et al. (1982) A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans. Am J Physiol 243: G226–230.LC SuS. RavanshadCA Owen JrJT McCallPE Zollman1982A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans.Am J Physiol243G226230

11. Muller T, van de Sluis B, Zhernakova A, van Binsbergen E, Janecke AR, et al. (2003) The canine copper toxicosis gene MURR1 does not cause non-Wilsonian hepatic copper toxicosis. J Hepatol 38: 164–168.T. MullerB. van de SluisA. ZhernakovaE. van BinsbergenAR Janecke2003The canine copper toxicosis gene MURR1 does not cause non-Wilsonian hepatic copper toxicosis.J Hepatol38164168

12. Coronado VA, Bonneville JA, Nazer H, Roberts EA, Cox DW (2005) COMMD1 (MURR1) as a candidate in patients with copper storage disease of undefined etiology. Clin Genet 68: 548–551.VA CoronadoJA BonnevilleH. NazerEA RobertsDW Cox2005COMMD1 (MURR1) as a candidate in patients with copper storage disease of undefined etiology.Clin Genet68548551

13. Burstein E, Hoberg JE, Wilkinson AS, Rumble JM, Csomos RA, et al. (2005) COMMD proteins, a novel family of structural and functional homologs of MURR1. J Biol Chem 280: 22222–22232.E. BursteinJE HobergAS WilkinsonJM RumbleRA Csomos2005COMMD proteins, a novel family of structural and functional homologs of MURR1.J Biol Chem2802222222232

14. Maine GN, Burstein E (2007) COMMD proteins: COMMing to the scene. Cell Mol Life Sci 64: 1997–2005.GN MaineE. Burstein2007COMMD proteins: COMMing to the scene.Cell Mol Life Sci6419972005

15. Maine GN, Mao X, Muller PA, Komarck CM, Klomp LW, et al. (2009) COMMD1 expression is controlled by critical residues that determine XIAP binding. Biochem J 417: 601–609.GN MaineX. MaoPA MullerCM KomarckLW Klomp2009COMMD1 expression is controlled by critical residues that determine XIAP binding.Biochem J417601609

16. Maine GN, Burstein E (2007) COMMD proteins and the control of the NF kappa B pathway. Cell Cycle 6: 672–676.GN MaineE. Burstein2007COMMD proteins and the control of the NF kappa B pathway.Cell Cycle6672676

17. Muller PA, van de Sluis B, Groot AJ, Verbeek D, Vonk WI, et al. (2009) Nuclear-cytosolic transport of COMMD1 regulates NF-kappaB and HIF-1 activity. Traffic 10: 514–527.PA MullerB. van de SluisAJ GrootD. VerbeekWI Vonk2009Nuclear-cytosolic transport of COMMD1 regulates NF-kappaB and HIF-1 activity.Traffic10514527

18. de Bie P, van de Sluis B, Burstein E, van de Berghe PV, Muller P, et al. (2007) Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. Gastroenterology 133: 1316–1326.P. de BieB. van de SluisE. BursteinPV van de BergheP. Muller2007Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.Gastroenterology13313161326

19. Tao TY, Liu F, Klomp L, Wijmenga C, Gitlin JD (2003) The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein. J Biol Chem 278: 41593–41596.TY TaoF. LiuL. KlompC. WijmengaJD Gitlin2003The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein.J Biol Chem2784159341596

20. Miyayama T, Hiraoka D, Kawaji F, Nakamura E, Suzuki N, et al. (2010) Roles of COMM-domain-containing 1 in stability and recruitment of the copper-transporting ATPase in a mouse hepatoma cell line. Biochem J 429: 53–61.T. MiyayamaD. HiraokaF. KawajiE. NakamuraN. Suzuki2010Roles of COMM-domain-containing 1 in stability and recruitment of the copper-transporting ATPase in a mouse hepatoma cell line.Biochem J4295361

21. Burstein E, Ganesh L, Dick RD, van De Sluis B, Wilkinson JC, et al. (2004) A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J 23: 244–254.E. BursteinL. GaneshRD DickB. van De SluisJC Wilkinson2004A novel role for XIAP in copper homeostasis through regulation of MURR1.EMBO J23244254

22. Vonk WI, de Bie P, Wichers CG, van den Berghe PV, van der Plaats R, et al. (2011) The copper-transporting capacity of ATP7A mutants associated with Menkes disease is ameliorated by COMMD1 as a result of improved protein expression. Cell Mol Life Sci. WI VonkP. de BieCG WichersPV van den BergheR. van der Plaats2011The copper-transporting capacity of ATP7A mutants associated with Menkes disease is ameliorated by COMMD1 as a result of improved protein expression.Cell Mol Life Sci

23. Thoms HC, Loveridge CJ, Simpson J, Clipson A, Reinhardt K, et al. (2010) Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination. Cancer Res 70: 139–149.HC ThomsCJ LoveridgeJ. SimpsonA. ClipsonK. Reinhardt2010Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination.Cancer Res70139149

24. Burkhead JL, Morgan CT, Shinde U, Haddock G, Lutsenko S (2009) COMMD1 Forms Oligomeric Complexes Targeted to the Endocytic Membranes via Specific Interactions with Phosphatidylinositol 4,5-Bisphosphate. J Biol Chem 284: 696–707.JL BurkheadCT MorganU. ShindeG. HaddockS. Lutsenko2009COMMD1 Forms Oligomeric Complexes Targeted to the Endocytic Membranes via Specific Interactions with Phosphatidylinositol 4,5-Bisphosphate.J Biol Chem284696707

25. Ke Y, Butt AG, Swart M, Liu YF, McDonald FJ (2011) COMMD1 downregulates the epithelial sodium channel through Nedd4-2. Am J Physiol Renal Physiol 298: F1445–1456.Y. KeAG ButtM. SwartYF LiuFJ McDonald2011COMMD1 downregulates the epithelial sodium channel through Nedd4-2.Am J Physiol Renal Physiol298F14451456

26. Maine GN, Mao X, Komarck CM, Burstein E (2007) COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase. EMBO J 26: 436–447.GN MaineX. MaoCM KomarckE. Burstein2007COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.EMBO J26436447

27. van de Sluis B, Groot AJ, Vermeulen J, van der Wall E, van Diest PJ, et al. (2009) COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70. PLoS One 4: e7332.B. van de SluisAJ GrootJ. VermeulenE. van der WallPJ van Diest2009COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.PLoS One4e7332

28. van de Sluis B, Mao X, Zhai Y, Groot AJ, Vermeulen JF, et al. (2010) COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion. J Clin Invest 120: 2119–2130.B. van de SluisX. MaoY. ZhaiAJ GrootJF Vermeulen2010COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.J Clin Invest12021192130

29. Vonk WI, Wijmenga C, Berger R, van de Sluis B, Klomp LW (2010) Cu,Zn superoxide dismutase maturation and activity are regulated by COMMD1. J Biol Chem 285: 28991–29000.WI VonkC. WijmengaR. BergerB. van de SluisLW Klomp2010Cu,Zn superoxide dismutase maturation and activity are regulated by COMMD1.J Biol Chem2852899129000

30. Biasio W, Chang T, McIntosh CJ, McDonald FJ (2004) Identification of Murr1 as a regulator of the human delta epithelial sodium channel. J Biol Chem 279: 5429–5434.W. BiasioT. ChangCJ McIntoshFJ McDonald2004Identification of Murr1 as a regulator of the human delta epithelial sodium channel.J Biol Chem27954295434

31. van de Sluis B, Muller P, Duran K, Chen A, Groot AJ, et al. (2007) Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice. Mol Cell Biol 27: 4142–4156.B. van de SluisP. MullerK. DuranA. ChenAJ Groot2007Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice.Mol Cell Biol2741424156

32. Postic C, Magnuson MA (2000) DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26: 149–150.C. PosticMA Magnuson2000DNA excision in liver by an albumin-Cre transgene occurs progressively with age.Genesis26149150

33. Lonnerdal B (2007) Trace element transport in the mammary gland. Annu Rev Nutr 27: 165–177.B. Lonnerdal2007Trace element transport in the mammary gland.Annu Rev Nutr27165177

34. Allen KJ, Buck NE, Cheah DM, Gazeas S, Bhathal P, et al. (2006) Chronological changes in tissue copper, zinc and iron in the toxic milk mouse and effects of copper loading. Biometals 19: 555–564.KJ AllenNE BuckDM CheahS. GazeasP. Bhathal2006Chronological changes in tissue copper, zinc and iron in the toxic milk mouse and effects of copper loading.Biometals19555564

35. Thornburg LP (2000) A perspective on copper and liver disease in the dog. J Vet Diagn Invest 12: 101–110.LP Thornburg2000A perspective on copper and liver disease in the dog.J Vet Diagn Invest12101110

36. Huster D, Finegold MJ, Morgan CT, Burkhead JL, Nixon R, et al. (2006) Consequences of copper accumulation in the livers of the Atp7b−/− (Wilson disease gene) knockout mice. Am J Pathol 168: 423–434.D. HusterMJ FinegoldCT MorganJL BurkheadR. Nixon2006Consequences of copper accumulation in the livers of the Atp7b−/− (Wilson disease gene) knockout mice.Am J Pathol168423434

37. Michalska AE, Choo KH (1993) Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci U S A 90: 8088–8092.AE MichalskaKH Choo1993Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse.Proc Natl Acad Sci U S A9080888092

38. He K, Chen Z, Ma Y, Pan Y (2011) Identification of high-copper-responsive target pathways in Atp7b knockout mouse liver by GSEA on microarray data sets. Mamm Genome. K. HeZ. ChenY. MaY. Pan2011Identification of high-copper-responsive target pathways in Atp7b knockout mouse liver by GSEA on microarray data sets.Mamm Genome

39. Huster D, Purnat TD, Burkhead JL, Ralle M, Fiehn O, et al. (2007) High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem 282: 8343–8355.D. HusterTD PurnatJL BurkheadM. RalleO. Fiehn2007High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease.J Biol Chem28283438355

40. Huster D, Lutsenko S (2007) Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism. Mol Biosyst 3: 816–824.D. HusterS. Lutsenko2007Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism.Mol Biosyst3816824

41. Lee J, Prohaska JR, Thiele DJ (2001) Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc Natl Acad Sci U S A 98: 6842–6847.J. LeeJR ProhaskaDJ Thiele2001Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development.Proc Natl Acad Sci U S A9868426847

42. Klomp AE, van de Sluis B, Klomp LW, Wijmenga C (2003) The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis. J Hepatol 39: 703–709.AE KlompB. van de SluisLW KlompC. Wijmenga2003The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis.J Hepatol39703709

43. Schosinsky KH, Lehmann HP, Beeler MF (1974) Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 20: 1556–1563.KH SchosinskyHP LehmannMF Beeler1974Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride.Clin Chem2015561563